Pretransplantation Levels of C-Reactive Protein Predict All-Cause and Cardiovascular Mortality, but Not Graft Outcome, in Kidney Transplant Recipients

American Journal of Kidney Diseases

Volumn 43, Issue 3, 2004, Pages 502-507

  Varagunam, Mira ^a   Finney, Hazel ^b   Trevitt, Ray ^b   Sharples, Edward ^b   McCloskey, Daniel J ^b   Sinnott, Paul J ^b   Raftery, Martin J ^b   Yaqoob, Muhammad M ^b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b NONE

Author keywords

C reactive protein (CRP); Cardiovascular mortality; Chlamydia seropositivity; Chronic allograft nephropathy (CAN); End stage renal failure (ESRF); Graft outcome

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CHOLESTEROL; CYCLOSPORIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PREDNISOLONE;

ADULT; ARTICLE; CHLAMYDIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT FAILURE; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; SURVIVAL;

EID: 1542287585     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2003.11.011     Document Type: Article

References (31)

1. Hariharan S: Long-term kidney transplant survival. Am J Kidney Dis 38:S44-S50, 2001 (suppl 6)
2. Kreis HA, Ponticelli C: Causes of late renal allograft loss: Chronic allograft dysfunction, death, and other factors. Transplantation 71:S5-S9, 2001 (suppl 11)
3. Panichi V, Migliori M, De Pietro S, et al: The link of biocompatibility to cytokine production. Kidney Int Suppl 76:S96-S103, 2000
4. Panichi V, Migliori M, De Pietro S, et al: C-Reactive protein as a marker of chronic inflammation in uremic patients. Blood Purif 18:183-190, 2000
5. Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P: Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17:1684-1688, 2002
6. Wanner C, Metzger T: C-Reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients. Nephrol Dial Transplant 17:S29-S32, 2002 (suppl 8)
7. Herzig KA, Purdie DM, Chang W, et al: Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? J Am Soc Nephrol 12:814-821, 2001
8. Tsirpanlis G, Chatzipanagiotou S, Ioannidis A, Moutafis S, Poulopoulou C, Nicolaou C: Detection of Chlamydia pneumoniae in peripheral blood mononuclear cells: Correlation with inflammation and atherosclerosis in haemodialysis patients. Nephrol Dial Transplant 18:918-923, 2003
9. Haubitz M, Brunkhorst R: C-Reactive protein and chronic Chlamydia pneumoniae infection-Long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol Dial Transplant 16:809-815, 2001
10. Laukoranta-Tolvanen SSE, Ronni T, Leinonen M, Saikku P, Laitinen K: Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae. Microb Pathog 21:407-411, 1996
11. Molestina RE, Dean D, Millar RD, Ramirez JA, Summersgill JT: Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis on the ompl gene and biological activity in human endothelial cells. Infect Immun 66:1370-1376, 1998
12. Hayry P, Aavik E, Savolanen H: Mechanisms of chronic rejection. Transplant Proc 31:S5-S8, 1999 (suppl 7A)
13. Volanakis JE: Complement activation by C-reactive protein complexes. Ann NY Acad Sci 389:235-250, 1982
14. Schweitzer EJ, Matas AJ, Gillingham K: Causes of renal allograft loss: Progress in the '80s, challenges for the '90s. Ann Surg 8:57-59, 1991
15. Kasiske BL, Guijarro C, Massey ZA, Wiederkehr MR, Ma JZ: Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7:158-165, 1996
16. Kaysen GA, Stevenson FT, Depner TA: Determinants of albumin concentrations in hemodialysis patients. Am J Kidney Dis 29:658-668, 1997
17. Fine A: Relevance of C-reactive protein levels in peritoneal dialysis patients. Kidney Int 61:615-620, 2002
18. Nordfors L, Stenvinkel P, Marchlewska A, et al: Molecular genetics in renal medicine: What can we hope to achieve? Nephrol Dial Transplant 17:S5-S11, 2002 (suppl 3)
19. Arici M, Wallis J: End stage renal disease, atherosclerosis and cardiovascular mortality: Is C-reactive protein the missing link? Kidney Int 59:407-414, 2001
20. Ortega O, Rodriguez I, Galler P, et al: Significance of high C-rcactive protein in pre-dialysis patients. Nephrol Dial Transplant 17:1105-1109, 2002
21. Fink JC, Onuigbo MA, Blahut SA, et al: Pretransplant serum C-reactive protein and the risk of chronic allograft nephropathy in renal transplant recipients: A case control study. Am J Kidney Dis 39:1096-1101, 2002
22. Sezer S, Ozdemir F, Alkay A, et al: Post transplant C-reactive protein monitoring predicts chronic rejection and renal allograft survival. Tissue Antigens 60:558-559, 2002
23. Ridker PM, Cushman M, Stamfer MJ, Vijit D: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979, 1997
24. Wanner C, Zimmerman J, Schwedler S, Metzger T: Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl 61:S99-S102, 2002
25. Noh H, Lee SW, Kang S, et al: Serum C-reactive protein: A predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 18:387-394, 1998
26. Griselli M, Herbert J, Hutchinson WL, et al: C-Reactive protein and complement are important mediators of tissue change in acute myocardial infarction. J Exp Med 190:1733-1739, 1999
27. Bhakdi S, Torzewski M, Klouche M, et al: Binding of CRP to degraded nonoxidized LDL enhances complement activation. Arterioscler Thromb Vasc Biol 19:2348-2354, 1999
28. Cermak J, Key NS, Bach RR, et al: C-Reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82:513-520, 1993
29. Pankow JS, Folsom AR, Cushman M, et al: Familial and genetic determinants of systemic markers of inflammation: The NHLIBI family heart study. Atherosclerosis 154: 681-689, 2001
30. Zoccalli C, Mallamaci F, Tripepi G: Atherosclerosis in dialysis patients: Does Chlamydia pneumoniae infection contribute to cardiovascular damage? Nephrol Dial Transplant 17:S25-S28, 2002 (suppl 8)
31. Tsirpanlis G, Chatzipanagiotou S, Ioannidid A, et al: The effect of viable Chlamydia pneumoniae on serum cytokines and adhesion molecules in haemodialysis patients. Kidney Int 63:72-75, 2003